BioGend Therapeutics Co Ltd

NEW
ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 24.05 +0.050 (+0.21%) Jul 24
At Loss
P/B:
4.04
Market Cap:
NT$ 3.23B ($ 99.98M)
Enterprise V:
NT$ 2.73B ($ 84.64M)
Volume:
51.00K
Avg Vol (2M):
222.47K
Trade In:
Volume:
51.00K
At Loss
Avg Vol (2M):
222.47K

BioGend Therapeutics Co Ltd Valuation Measures